Bosutinib Tablet, Film Coated
Product Images NDC 75907-405

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bosutinib (NDC 75907-405). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bosutinib-400-mg-30s-count (Bosutinib 400 mg 30s Count)

Bosutinib Tablets 400 mg film-coated tablets packaging label showing Dr. Reddy's Laboratories Inc. as the labeler. The label includes storage instructions, quantity of 30 tablets, and warnings such as 'Do not crush or cut tablet' and 'For Oncology Use Only.' The label also displays barcodes and manufacturing details with the NDC 75907-405.*

FDA Label Image

Bosutinib-structure (Bosutinib Structure)

Chemical structure of the active ingredient Bosutinib, showing the molecular arrangement including chlorine atoms, methoxy groups, a cyano group, and characteristic nitrogen-containing rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.